# Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

> **NCT02854943** · — · COMPLETED · sponsor: **Gunnar Lachmann** · enrollment: 2623 (actual)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis (HLH)
- Macrophage Activation Syndrome (MAS)
- Hemophagocytic Syndromes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02854943
- **Lead sponsor:** Gunnar Lachmann
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 2623 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854943, "Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02854943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*